Skip to menu Skip to content Skip to footer

2015

Journal Article

Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice

Wikstrom, Matthew E., Fleming, Peter, Kuns, Rachel D., Schuster, Iona S., Voigt, Valentina, Miller, Gregory, Clouston, Andrew D., Tey, Siok-Keen, Andoniou, Christopher E., Hill, Geoffrey R. and Degli-Esposti, Mariapia A. (2015). Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice. Blood, 126 (12), 1503-1514. doi: 10.1182/blood-2015-01-622837

Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice

2015

Conference Publication

Idelalisib-induced acute proctocolitis: clinical and histological findings

Hendy, P., Rosty, C., Bashford, J., Clouston, A. and Burger, D. (2015). Idelalisib-induced acute proctocolitis: clinical and histological findings. Gastro 2015 GESA‐AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015, Brisbane, QLD, Australia, 28 September‐2 October 2015. Hoboken, NJ, United States: Wiley-Blackwell Publishing. doi: 10.1111/jgh.13094

Idelalisib-induced acute proctocolitis: clinical and histological findings

2015

Journal Article

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

Irvine, Katharine M., Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin J., Horsfall, Leigh U., Fletcher, Linda M., Ungerer, Jacobus P. J., Pretorius, Carel J., Miller, Gregory C., Clouston, Andrew D., Lampe, Guy and Powell, Elizabeth E. (2015). The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver International, 36 (3), 370-377. doi: 10.1111/liv.12896

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

2015

Journal Article

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

Fagan, Kevin J., Pretorius, Carel J., Horsfall, Leigh U., Irvine, Katharine M., Wilgen, Urs, Choi, Kihoon, Fletcher, Linda M., Tate, Jill, Melino, Michelle, Nusrat, Sharmin, Miller, Gregory C., Clouston, Andrew D., Ballard, Emma, O'Rourke, Peter, Lampe, Guy, Ungerer, Jacobus P. J. and Powell, Elizabeth E. (2015). ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. Liver International, 35 (6), 1673-1681. doi: 10.1111/liv.12760

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

2015

Journal Article

Effect of resveratrol on experimental non-alcoholic steatohepatitis

Heeboll, Sara, Thomsen, Karen Louise, Clouston, Andrew, Sundelin, Elias Immanuel, Radko, Yulia, Christensen, Lars Porskjaer, Ramezani-Moghadam, Mehdi, Kreutzfeldt, Martin, Pedersen, Steen Bonlokke, Jessen, Niels, Hebbard, Lionel, George, Jacob and Gronbaek, Henning (2015). Effect of resveratrol on experimental non-alcoholic steatohepatitis. Pharmacological Research, 95-96, 34-41. doi: 10.1016/j.phrs.2015.03.005

Effect of resveratrol on experimental non-alcoholic steatohepatitis

2015

Journal Article

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma

Whiteman, David C., Appleyard, Mark, Bahin, Farzan F., Bobryshev, Yuri V., Bourke, Michael J., Brown, Ian, Chung, Adrian, Clouston, Andrew, Dickins, Emma, Emery, Jon, Eslick, Guy D., Gordon, Louisa G., Grimpen, Florian, Hebbard, Geoff, Holliday, Laura, Hourigan, Luke F., Kendall, Bradley J., Lee, Eric Y. T., Levert-Mignon A., Lord, Reginald V., Lord, Sarah J., Maule, Derek, Moss, Alan, Norton, Ian, Olver, Ian, Pavey, Darren, Raftopoulos, Spiro, Rajendra, Shan, Schoeman, Mark ... Yusoff, Ian F. (2015). Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology (Australia), 30 (5), 804-820. doi: 10.1111/jgh.12913

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma

2015

Journal Article

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation

Varelias, Antiopi, Gartlan, Kate H., Kreijveld, Ellen, Olver, Stuart D., Lor, Mary, Kuns, Rachel D., Lineburg, Katie E., Teal, Bianca E., Raffelt, Neil C., Cheong, Melody, Alexander, Kylie A., Koyama, Motoko, Markey, Kate A., Sturgeon, Elise, Leach, Justine, Reddy, Pavan, Kennedy, Glen A., Yanik, Gregory A., Blazar, Bruce R., Tey, Siok-Keen, Clouston, Andrew D., MacDonald, Kelli P. A., Cooke, Kenneth R. and Hill, Geoffrey R. (2015). Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood, 125 (15), 2435-2444. doi: 10.1182/blood-2014-07-590232

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation

2015

Journal Article

Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply

Bedossa, Charles, Burt, Alastair D, Brunt, Elizabeth, Callea, Francesco, Clouston, Andrew D, Dienes, Hans Peter, Goodman, Zachary D, Gouw, Annette S. H, Hubscher, Stefan G, Roberts, Eve A, Roskams, Tania, Terracciano, Luigi, Tiniakos, Dina G, Torbenson, Michael S and Wanless, Ian R (2015). Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply. Human Pathology, 46 (4), 635-636. doi: 10.1016/j.humpath.2014.10.030

Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply

2015

Journal Article

Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice

Bridle, Kim R., Sobbe, Amy L., de Guzman, C. Erika, Santrampurwala, Nishreen, Jaskowski, Lesley A., Clouston, Andrew D., Campbell, Catherine M., Nathan Subramaniam, V. and Crawford, Darrell H. G. (2015). Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice. Liver International, 35 (4), 1451-1463. doi: 10.1111/liv.12494

Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice

2015

Conference Publication

EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS

Heeboll, S., Thomsen, K. L., Clouston, A., Jessen, N., Sundelin, E. I., Pedersen, S. B., Radko, Y., Christensen, L. P., Hebbard, L., Gronbaek, H. and George, J. (2015). EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS. 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna Austria, Apr 22-26, 2015. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(15)31175-2

EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS

2015

Journal Article

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox

Sobbe, Amy, Bridle, Kim R., Jaskowski, Lesley, de Guzman, C. Erika, Santrampurwala, Nishreen, Clouston, Andrew D., Campbell, Catherine M., Subramaniam, V. Nathan and Crawford, Darrell H. G. (2015). Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox. Journal of Gastroenterology and Hepatology, 30 (3), 638-645. doi: 10.1111/jgh.12720

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox

2015

Journal Article

A clinicopathological and molecular analysis of 200 traditional serrated adenomas

Bettington, Mark L., Walker, Neal I., Rosty, Christophe, Brown, Ian S., Clouston, Andrew D., McKeone, Diane M., Pearson, Sally Ann, Klein, Kerenaftali, Leggett, Barbara A. and Whitehall, Vicki L. (2015). A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Modern Pathology, 28 (3), 414-427. doi: 10.1038/modpathol.2014.122

A clinicopathological and molecular analysis of 200 traditional serrated adenomas

2015

Journal Article

Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease

Croese, John, Giacomin, Paul, Navarro, Severine, Clouston, Andrew, McCann, Leisa, Dougall, Annette, Ferreira, Ivana, Susianto, Atik, O'Rourke, Peter, Howlett, Mariko, McCarthy, James, Engwerda, Christian, Jones, Dianne and Loukas, Alex (2015). Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. Journal of Allergy and Clinical Immunology, 135 (2), 508-516.e5. doi: 10.1016/j.jaci.2014.07.022

Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease

2015

Conference Publication

A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia

Bettington, Mark, Walker, Neal, Rosty, Christophe, Brown, Ian, Clouston, Andrew, Pearson, Sally-Ann, McKeone, Diane, Leggett, Barbara and Whitehall, Vicki (2015). A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia. 104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston, MA, United States, 21-27 March 2015. London, United Kingdom: Nature Publishing Group.

A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia

2015

Journal Article

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection

Tu, T, Mason, W.S, Clouston, A.D, Shackel, N.A, Mccaughan, G.W, Yeh, M.M, Schiff, E.R, Ruszkiewicz, A.R, Chen, J.W, Harley, H.A.J, Stroeher, U.H and Jilbert, A.R (2015). Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. Journal of Viral Hepatitis, 22 (9), 737-753. doi: 10.1111/jvh.12380

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection

2015

Conference Publication

Idelalisib-induced acute proctocolitis: Clinical and histological findings

Hendy, P., Rosty, C., Bashford, J., Clouston, A. and Burger, D. (2015). Idelalisib-induced acute proctocolitis: Clinical and histological findings. 10th Congress of ECCO, Barcelona, Spain, February 18-21, 2015. HOBOKEN: WILEY-BLACKWELL.

Idelalisib-induced acute proctocolitis: Clinical and histological findings

2015

Conference Publication

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores

Irvine, Katharine, Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin, Horsfall, Leigh, Fletcher, Linda, Ungerer, Jacobus, Pretorius, Carel J., Miller, Gregory, Clouston, Andrew D., Lampe, Guy and Powell, Elizabeth E. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, United States, 13-17 November 2015. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.28218

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores

2015

Conference Publication

A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia

Bettington, Mark, Walker, Neal, Rosty, Christophe, Brown, Ian, Clouston, Andrew, Pearson, Sally-Ann, McKeone, Diane, Leggett, Barbara and Whitehall, Vicki (2015). A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia. 104th Annual Meeting of the United States and Canadian Academy of Pathology, Boston, United States, 21-27 March, 2015. London, United Kingdom: Nature Publishing Group. doi: 10.1038/labinvest.2015.11

A clinicopathological and molecular analysis of 107 sessile serrated adenomas with dysplasia

2015

Conference Publication

Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation

Irvine, K. M., Clouston, A. D., Blumenthal, A. and Powell, E. E. (2015). Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD, Australia, 28 September - 2 October 2015. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.13087

Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation

2015

Conference Publication

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores

Irvine, K. M., Wockner, L. F., Shanker, M., Fagan, K. J., Horsfall, L. U., Fletcher, L. M., Ungerer, J., Pretorius, C. J., Miller, G. C., Clouston, A. D., Lampe, G. and Powell, E. E. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 | World Congress of Gastroenterology, Brisbane, QLD, Australia, 28 September-2 October 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13093

Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores